J. Safra Sarasin Holding’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26M Buy
92,059
+58,549
+175% +$1.53M 0.03% 244
2026
Q1
$940K Sell
33,510
-3,441
-9% -$91.6K 0.02% 299
2025
Q4
$920K Buy
+36,951
New +$932K 0.02% 322
2025
Q3
Sell
-143,246
Closed -$3.47M 529
2025
Q2
$3.47M Buy
143,246
+26,463
+23% +$617K 0.06% 158
2025
Q1
$2.96M Buy
116,783
+61,212
+110% +$1.6M 0.05% 173
2024
Q4
$1.47M Sell
55,571
-123,322
-69% -$3.35M 0.02% 273
2024
Q3
$5.18M Buy
178,893
+68,406
+62% +$2M 0.09% 134
2024
Q2
$3.09M Buy
+110,487
New +$3.04M 0.06% 172

Other funds holding PFE

J. Safra Sarasin Holding's PFE Position: Q2 2026 in Review

J. Safra Sarasin Holding increased its Pfizer (PFE) stake by 175% in Q2 2026, buying an estimated $1.53M and bringing the position to 92,059 shares worth $2.26M. The position accounts for 0.03% of the portfolio, ranked #244.

J. Safra Sarasin Holding first reported a position in PFE in Q2 2024 and has held it in 8 quarters since. The position peaked at $5.18M in Q3 2024. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • J. Safra Sarasin Holding held 92,059 shares of Pfizer worth $2.26M as of Q2 2026.
  • J. Safra Sarasin Holding bought 58,549 Pfizer shares in Q2 2026, an estimated $1.53M.
  • Pfizer made up 0.03% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #244 holding.
  • J. Safra Sarasin Holding first reported a position in Pfizer in Q2 2024 and has held it in 8 quarters since.
  • J. Safra Sarasin Holding's Pfizer position peaked at $5.18M in Q3 2024.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.